标题
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720
作者
关键词
-
出版物
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2023-10-21
DOI
10.1080/14787210.2023.2270158
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus
- (2022) Wassihun Wedajo Aragaw et al. Microbiology Spectrum
- Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis
- (2022) Yunchun Zhou et al. BMJ Open
- The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease
- (2022) Ping-Huai Wang et al. Frontiers in Microbiology
- Treatment of Nontuberculous Mycobacterial Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines
- (2022) Jennifer H Ku et al. CLINICAL INFECTIOUS DISEASES
- Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review
- (2022) Victor Naestholt Dahl et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The benzimidazole SPR719 shows promising concentration-dependent activity and synergy against nontuberculous mycobacteria
- (2021) Lian J. Pennings et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections
- (2021) Angela K. Talley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence and Clinical Characteristics of Nontuberculous Mycobacteria in Patients with Bronchiectasis: A Systematic Review and Meta-Analysis
- (2021) Ya-nan Zhu et al. RESPIRATION
- In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera
- (2021) Sacha J. Pidot et al. PLoS Neglected Tropical Diseases
- Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality
- (2021) Yunjoo Im et al. CHEST
- Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria
- (2021) Herman O.I. Pfaeffle et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease
- (2021) Dae Hun Kim et al. Journal of Clinical Medicine
- Advancement of GyrB Inhibitors for Treatment of Infections Caused by Mycobacterium tuberculosis and Non-tuberculous Mycobacteria
- (2020) Suzanne S. Stokes et al. ACS Infectious Diseases
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
- (2020) Charles L. Daley et al. EUROPEAN RESPIRATORY JOURNAL
- Structural and mechanistic analysis of ATPase inhibitors targeting mycobacterial DNA gyrase
- (2020) Sara R Henderson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonary Mycobacterium avium complex disease: A propensity score analysis
- (2020) Hisayuki Shuto et al. PLoS One
- Development of Drugs for Nontuberculous Mycobacterial Disease
- (2020) Patrick A. Flume et al. CHEST
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
- (2020) Charles L Daley et al. CLINICAL INFECTIOUS DISEASES
- ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents
- (2019) Martina Durcik et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease
- (2018) Roland Diel et al. CHEST
- NTM drug discovery: status, gaps and the way forward
- (2018) Mu-Lu Wu et al. DRUG DISCOVERY TODAY
- In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, Against Nontuberculous Mycobacteria
- (2018) Barbara A. Brown-Elliott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic Review
- (2018) Sanne Zweijpfenning et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
- (2017) Won-Jung Koh et al. EUROPEAN RESPIRATORY JOURNAL
- New insights in the treatment of nontuberculous mycobacterial pulmonary disease
- (2017) Mike Marvin Ruth et al. Future Microbiology
- Epidemiology and Predictors of NTM Pulmonary Infection in Taiwan - a Retrospective, Five-Year Multicenter Study
- (2017) Hung-Ling Huang et al. Scientific Reports
- Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche
- (2017) Sarah A McGuffin et al. Open Forum Infectious Diseases
- Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
- (2016) Julie Jarand et al. CHEST
- Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB
- (2016) Kavita Chaudhari et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease
- (2016) Theodore K. Marras et al. EUROPEAN RESPIRATORY JOURNAL
- Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
- (2016) David C. Hooper et al. Cold Spring Harbor Perspectives in Medicine
- Environmental Sources of Nontuberculous Mycobacteria
- (2015) Joseph O. Falkinham CLINICS IN CHEST MEDICINE
- Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria
- (2015) D. Rebecca Prevots et al. CLINICS IN CHEST MEDICINE
- A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
- (2014) Christopher P. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic review/Meta-analysis Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis
- (2014) Haiqing Chu et al. Archives of Medical Science
- Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
- (2014) Richard J. Wallace et al. CHEST
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
- (2013) Wouter Hoefsloot et al. EUROPEAN RESPIRATORY JOURNAL
- Evaluation of WO2012177707 and WO2012097269: Vertex's phosphate prodrugs of gyrase and topoisomerase antibacterial agents
- (2013) John Finn EXPERT OPINION ON THERAPEUTIC PATENTS
- Underlying Host Risk Factors for Nontuberculous Mycobacterial Lung Disease
- (2013) Michael Iseman et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships
- (2008) Paul S. Charifson et al. JOURNAL OF MEDICINAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started